Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Detaylı Bibliyografya
Yazar:	Paul, Pulock
Diğer Yazarlar:	Azam,Faruque
Materyal Türü:	Tez
Dil:	English
Baskı/Yayın Bilgisi:	Brac University 2024
Konular:	Lung cancer Clinical trial Efficacy endpoints Targeted therapy Lungs > Cancer Clinical trials Chemotherapy
Online Erişim:	http://hdl.handle.net/10361/23954

Benzer Materyaller

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
Yazar:: Rahman, Tasnim
Baskı/Yayın Bilgisi: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
Yazar:: Hoque, Ismoth Ara
Baskı/Yayın Bilgisi: (2024)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
Yazar:: Karim, Samia Binte
Baskı/Yayın Bilgisi: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
Yazar:: Flora, Sanzida Alam
Baskı/Yayın Bilgisi: (2024)

A review on targeted therapies for lung cancer
Yazar:: Ashraf, Anushey
Baskı/Yayın Bilgisi: (2023)

Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
Yazar:: Shobnam, Sohana
Baskı/Yayın Bilgisi: (2024)

Molecules associated with the development of lung cancer
Yazar:: Rahman, Adree, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
Yazar:: Tania, Umme
Baskı/Yayın Bilgisi: (2023)

Protein biomarkers for Lung Cancer: a bioinformatic approach
Yazar:: Jeba, Joynob
Baskı/Yayın Bilgisi: (2017)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
Yazar:: Bristy, Israt Zerin
Baskı/Yayın Bilgisi: (2021)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
Yazar:: Razna, Amrin Islam
Baskı/Yayın Bilgisi: (2019)

Potential of liposomes for the treatment of lung cancer- a review
Yazar:: Mim, Shanzida
Baskı/Yayın Bilgisi: (2023)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
Yazar:: Zangmo, Thinley
Baskı/Yayın Bilgisi: (2024)

A review on recent advances in drugs for lung cancer treatment
Yazar:: Noor, Fouzia
Baskı/Yayın Bilgisi: (2024)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
Yazar:: Hasan, Sakib
Baskı/Yayın Bilgisi: (2024)

A systematic review on the efficacy of Fluoxetine in the management of anxiety disorders
Yazar:: Akter, Rabia
Baskı/Yayın Bilgisi: (2024)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
Yazar:: Pial, Sazia Afrin
Baskı/Yayın Bilgisi: (2018)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
Yazar:: Shabnam, Musharrat
Baskı/Yayın Bilgisi: (2018)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
Yazar:: Das, Reshita
Baskı/Yayın Bilgisi: (2024)

Immunotherapy in the Management of Lung Cancer
Yazar:: Tasnim, Humayra
Baskı/Yayın Bilgisi: (2022)

A review on the potential of repurposing of metformin for colon cancer and breast cancer
Yazar:: Oishy, Jannatun Noor
Baskı/Yayın Bilgisi: (2024)

Comparative efficacy of Sorafenib, and Lenvatinib in Hepatocellular Carcinoma: a meta-analysis
Yazar:: Monayem, Kazi Fahim
Baskı/Yayın Bilgisi: (2024)

Lung cancer detection and classification using machine learning
Yazar:: Arefin, Mahbubul, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
Yazar:: Mukti, Roushney Fatima, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
Yazar:: Nandy, Aditi
Baskı/Yayın Bilgisi: (2022)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
Yazar:: Abir, Shifaty Nur
Baskı/Yayın Bilgisi: (2024)

The hidden histories of war crimes trials /

A review on drug repurposing for diabetes epidemic
Yazar:: Lamia, Sadia Raisa
Baskı/Yayın Bilgisi: (2022)

Update on pharmacological aspects of carotenoids: molecules of pharmaceutical promise
Yazar:: Labanna, Marium Akther
Baskı/Yayın Bilgisi: (2022)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
Yazar:: Rahman, Sanjida
Baskı/Yayın Bilgisi: (2024)

Changing global policy to deliver safe, equitable, and affordable care for women's cancers
Yazar:: Ginsburg, Ophira M., ve diğerleri
Baskı/Yayın Bilgisi: (2018)

A review of Breast Cancer risk factor assessment on women in developing countries, cancer drug resistance, and Breast Cancer treatment in Bangladesh
Yazar:: Raihan, Dilraj
Baskı/Yayın Bilgisi: (2024)

Tuberculosis associates with both airflow obstruction and low lung function: BOLD results
Yazar:: F. S. Amaral, André, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
Yazar:: Nahar, Kamrun
Baskı/Yayın Bilgisi: (2023)

Semantic segmentation with attention dense U-net for lung extraction from X-ray images
Yazar:: Auvy, Akib Al Mahmud, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Gene therapy for rare genetic disorders
Yazar:: Tanjum, Atia
Baskı/Yayın Bilgisi: (2024)

Economic evaluation of culprit lesion only PCI vs. immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock: the CULPRIT‑SHOCK trial
Yazar:: Robles‑Zurita, Jose Antonio, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Hypothesizing precise cancer treatments based on patient survival using machine learning & deep learning
Yazar:: Sakib, Hasibul, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
Yazar:: Hossain, Safa Binte
Baskı/Yayın Bilgisi: (2019)

Targeted therapeutic options in the treatment of Breast Cancer
Yazar:: Alam, Kazi Tasnuva
Baskı/Yayın Bilgisi: (2022)